International Patent: ENGINEERED NANOVESICLE DERIVED FROM APOPTOTIC MESENCHYMAL STEM CELL, COMPOSITE HYDROGEL, PREPARATION METHOD AND USE

GENEVA, July 6 -- SHANGHAI SKIN DISEASE HOSPITAL filed a patent application (CN2025/132243) for “ENGINEERED NANOVESICLE DERIVED FROM APOPTOTIC MESENCHYMAL STEM CELL, COMPOSITE HYDROGEL, PREPARATION METHOD AND USE”. With publication no. WO/2026/138178, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/0775

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....